Carsten Bönnemann graduated from Medical School at the University of Freiburg in Germany. He trained in pediatrics in Hamburg and Göttingen (where he was awarded the habilitation in pediatrics), and in neurology/child neurology at Massachusetts General Hospital/Harvard Medical School in Boston. He did postdoctoral research in genetics and neuromuscular specialty training at Boston Children’s Hospital/Harvard Medical School. From 2002 he was Co-Director of the Neuromuscular Program and Director of the Pediatric Neurogenetics Clinic at Children's Hospital of Philadelphia/University of Pennsylvania School of Medicine, where he continues to be on faculty as Adjunct Full Professor of Neurology. In 2010 he joined the NIH as a tenured Senior Investigator and Chief of the Neuromuscular and Neurogenetic Disorders of Childhood Section in the Neurogenetics Branch of the National Institute of Neurological Disorders and Stroke. Clinical, genomic and translational work in the Section centers in particular around early onset neuromuscular disorders such as the congenital myopathies and congenital muscular dystrophies and on the development of molecular and gene directed treatment approaches to these conditions, including first-in-human intrathecal and intravenous AAV mediated gene transfer trials. From March of 2026 Dr Bönnemann will serve as the inaugural Chair of the Department of Genomic and Translational Neuroscience at St. Jude Children’s Research Hospital. Dr. Bönnemann was a Pew Fellow in the Biomedical Sciences, he received the 2010 Derek Denny-Brown Neurological Scholar Award and the 2023 Jacoby Award from the American Neurological Association, in 2022 the Legacy Award of the Muscular Dystrophy Association USA and in 2023 the International Duchenne-Erb Price of the German DGM. He has been elected to the American Association of Physicians (AAP) and is Co-Editor-in-Chief of the Journal of Neuromuscular Diseases (JND).